{ "ProductData": { "RelatedLinks": "", "RegulatoryDisclaimer1": "For further processing only.", "RegulatoryDisclaimer2": "", "StainLocalization": [ "" ], "ProductType": "Others", "DisclaimerGroup2": null, "ProductNameGlobal": "cOmplete EDTA free", "DisclaimerGroup1": "Non-IVD", "ControlTissue": [ "" ], "BrandName": "cOmplete, EDTA free", "LicenseDisclaimers": [ ], "Isotypes": "", "RegulatoryDisclaimer3": "", "ID": "3.2.7.1.40.1", "ProductNameAddition": "7500 tablets in glass vial", "Species": [ "" ], "Clone": "" }, "ProductImageDetails": { "ImagePath": "https://pim-media.roche.com/Images/CB_IMAGE.png", "ImageType": "Image main" }, "Product2Taxomony": { "Product2TaxomonyReferences": [ { "StructureSystemIdentifier": "OWP_Product_Types", "StructureSystemName": "Product Types", "NodeName": "Protease inhibitors", "NodeID": "70-043-00" }, { "StructureSystemIdentifier": "OWP_Organization", "StructureSystemName": "Organization", "NodeName": "CustomBiotech and LifeScience", "NodeID": "01-01-01-07-00" }, { "StructureSystemIdentifier": "OWP_Family", "StructureSystemName": "Product Families", "NodeName": "cOmplete", "NodeID": "624" }, { "StructureSystemIdentifier": "Product_Solutions", "StructureSystemName": "Product Solutions", "NodeName": "CustomBiotech", "NodeID": "520" }, { "StructureSystemIdentifier": "Product_Grouping", "StructureSystemName": "Product Grouping", "NodeName": "Clinical Chemistry Raw Materials", "NodeID": "02-0011" }, { "StructureSystemIdentifier": "Lab_Type", "StructureSystemName": "Lab Types", "NodeName": "Manufacturing", "NodeID": "180-00" }, { "StructureSystemIdentifier": "Applications", "StructureSystemName": "Applications", "NodeName": "NOT APPLICABLE", "NodeID": "99-00-00" }, { "StructureSystemIdentifier": "OWP_Techniques", "StructureSystemName": "Techniques", "NodeName": "NOT APPLICABLE", "NodeID": "999-00" }, { "StructureSystemIdentifier": "Disease_Areas", "StructureSystemName": "Disease Areas", "NodeName": "NOT APPLICABLE", "NodeID": "99-00-00" }, { "StructureSystemIdentifier": "Pathogens", "StructureSystemName": "Pathogens", "NodeName": "NOT APPLICABLE", "NodeID": "99-00-00" }, { "StructureSystemIdentifier": "Health_Topics", "StructureSystemName": "Health Topics", "NodeName": "NOT APPLICABLE", "NodeID": "99-00-00" } ] }, "Product2Materials": { "P2MaterialReferences": [ { "MaterialNum": "04574834001", "MaterialDescription": "Complete EDTA-free Bulk for RAS", "RegisteredProductName": "cOmplete, EDTA free", "GTIN": "", "ProductCategoryText": "Non-finished products", "OldMaterialNumber": "", "PackSizePIM360": "7500 tablets in glass vial", "PackSizeDescPIM360": "", "MaterialAnnotation": "CustomBiotech product. Please contact your local representative.", "ReadyForUse": "", "OrderInformation": "Will be supplied as ''cOmplete''. Unit of measure is ''piece''." } ] }, "Product2Products": { "Product2ProductReference": [ ] }, "ProductSpec": [ { "ProductSpecVariant": { "Chapters": [ { "Language": "en", "Value": "cOmplete, EDTA-free, protease inhibitor cocktail tablets are used for the inhibition of a broad spectrum of serine and cysteine proteases. The inhibitor is ideal for the inhibition of proteolytic activity in larger volumes (up to 50mL), in which EDTA may interfere with protein stability or subsequent assays. Due to the optimized tablet composition, they show excellent inhibition effects and are well suited for the protection of proteins isolated from: Mammalian tissue
  • Bacteria
  • Yeast
  • Plants
cOmplete, EDTA-free contains both irreversible and reversible protease inhibitors. As they do not contain EDTA both stability and function of metal-dependent proteins remain unaffected. The affinity purification of Poly-His tagged fusion proteins via IMAC is also facilitated (no dialysis necessary).", "Name": "Applications" }, { "Language": "en", "Value": "Mix of protease inhibitors", "Name": "Positioning" }, { "Language": "en", "Value": "Will be supplied as ''cOmplete''. Unit of measure is ''piece''.", "Name": "CB - Order Information" }, { "Language": "en", "Value": "Appearance: White tablets
Resolving time: ≤180 seconds
Abrasion: ≤1.0%
Diameter of tablets (average): 6 mm
Height of tablets (average): 1.75-2.00 mm
Weight of tablets (average): 56.0-66.0 mg
Homogenity of lot (based on weight of tablets): S<3.0
Inhibition of pancrease, chymotrypsin and thermolysin (after 60 minutes at +20 to +25°C):
pancrease: ≥90%
chymotrypsin: ≥90%
thermolysin: ≤15%
Stability: At +2 to +8°C within specification range for 24 months.", "Name": "Specification" } ] } } ] }

cOmplete, EDTA free

7500 tablets in glass vial

logo